Advanced Human Imaging Ltd (ASX: AHI) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Advanced Human Imaging Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $30.85 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 166.75 million
Earnings per share -0.168
Dividend per share N/A
Year To Date Return -79.56%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Advanced Human Imaging Ltd (ASX: AHI)
Latest News

Kid with a brown paper bag on his head which has a sad face on it sits in front of an old style computer representing falling ASX 200 tech shares today
Technology Shares

Here’s a look at the laggards from ASX tech shares last quarter

No comeback for tech players yet in 2022.

Read more »

A man wearing a white coat and glasses is wide-mouthed in surprise.
Technology Shares

Why has the Advanced Human Imaging (ASX:AHI) share price plummeted 57% in a month?

Here's what might be weighing on the imaging technology company's stock lately.

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
Technology Shares

Up 27% this week, what’s with the Advanced Human Imaging (ASX:AHI) share price?

Why is Advanced Human Imaging impressing investors this week?

Read more »

Man and woman jumnp in the air and high five with both hands on a road after running.
Technology Shares

The Advanced Human Imaging (ASX:AHI) share price is leaping 46%. Why?

What's making the Advanced Human Imaging share price explode today?

Read more »

Graph showing a fall in share price.
Technology Shares

What sent the Advanced Human Imaging (ASX:AHI) share price down 18% today?

The software company has just completed its US IPO.

Read more »

Man in business suit crouched and freezing in a block of ice.
Technology Shares

Here’s why the Advanced Human Imaging (ASX:AHI) share price is frozen

The company is seemingly preparing to release an update on its planned US listing

Read more »

falling healthcare asx share price represented by doctor grimacing at x-ray
Technology Shares

Advanced Human Imaging (ASX:AHI) share price sinks on US listing update

Shares in the human scanning technology provider are on the nose for investors today.

Read more »

share price dropping
Share Fallers

Why Advanced Human Imaging, ResMed, Western Areas, and Westpac are falling

These ASX shares are starting the week in the red...

Read more »

AHI ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Advanced Human Imaging Ltd

A software company that has developed a software application MyFiziq Technology and App for Smart Phones. The app converts photos of the human body into 3D image known as a Personal Avatar.

Formerly MyFiziq Limited (MYQ)

AHI Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 May 2022 $0.19 $0.00 0.00% 98,961 $0.19 $0.20 $0.19
13 May 2022 $0.19 $-0.01 -5.13% 242,073 $0.20 $0.20 $0.19
12 May 2022 $0.20 $-0.01 -5.00% 135,183 $0.21 $0.21 $0.19
11 May 2022 $0.20 $-0.01 -4.76% 207,598 $0.21 $0.21 $0.20
10 May 2022 $0.21 $0.01 4.88% 717,333 $0.20 $0.21 $0.19
09 May 2022 $0.21 $-0.02 -9.09% 93,560 $0.22 $0.23 $0.21
06 May 2022 $0.22 $0.01 4.65% 151,902 $0.20 $0.22 $0.20
05 May 2022 $0.22 $0.02 10.00% 17,577 $0.22 $0.22 $0.21
04 May 2022 $0.20 $-0.02 -9.30% 604,096 $0.21 $0.22 $0.20
03 May 2022 $0.22 $0.01 4.88% 94,593 $0.21 $0.23 $0.20
02 May 2022 $0.21 $0.00 0.00% 316,485 $0.20 $0.21 $0.20
29 Apr 2022 $0.21 $-0.02 -8.89% 215,339 $0.23 $0.23 $0.21
28 Apr 2022 $0.23 $-0.02 -8.16% 190,907 $0.24 $0.24 $0.22
27 Apr 2022 $0.25 $0.02 8.70% 306,339 $0.23 $0.25 $0.22
26 Apr 2022 $0.23 $0.00 0.00% 106,715 $0.25 $0.25 $0.23
22 Apr 2022 $0.24 $-0.01 -4.17% 117,257 $0.24 $0.24 $0.24
21 Apr 2022 $0.24 $-0.01 -4.08% 178,255 $0.24 $0.24 $0.24
20 Apr 2022 $0.25 $0.01 4.17% 165,887 $0.25 $0.25 $0.24

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
08 Feb 2022 Michael (Mike) Melby Issued 1 $410,000
Issue of securities.
08 Feb 2022 Nicholas (Nick) Prosser Issued 1 $410,000
Issue of securities.
08 Feb 2022 Edward Greissing Jr Issued 700 $287,000
Issue of options.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Katherine Iscoe Chief Executive OfficerExecutive Director Feb 2022
Dr Iscoe has academic and practical experience in medical sciences, health and wellness. Dr Iscoe has co-founded Advanced Human Imaging in 2014 and served as its CEO from April 2015 until October 2016. She has experience in Type 1 Diabetes and glucose optimization through continuous glucose monitoring systems (CGMS). Her work in Type 1 Diabetes spanned several years and includes publications in multiple international peer-reviewed journals. Her biomedical research has provided insight on the differences between interstitial glucose and blood glucose levels, which result in a measurement reading when using CGMS.
Mr Michael (Mike) Melby Non-Executive Director Oct 2017
Mr Melby is co-founder & co-Chief Executive Officer of FitLab, an integrated media & technology holding company focused on fitness & sport lifestyle. He is also co-founder of Mayweather Boxing + Fitness. Previously, Mr Melby was Vice President at New Evolution Ventures, where he invested in and operated health clubs worldwide and served as an executive at UFC Gym. Prior to that, he was co-founder of two technology startups (both of which exited to publicly traded companies), a private equity investor with ClearLight Partners and an investment banker with FBR Capital Markets. Mr Melby has not served as a director of any other listed companies in the 3 years immediately before the end of the 2021 financial year.
Mr Nicholas (Nick) Prosser Non-Executive DirectorInterim Chairman Apr 2018
Mr Prosser has over a decade of experience in technology expansion and monetization. Mr Prosser has been serving on the Board of Directors of numerous ASX listed companies. He is a founder of Canberra Data Centres, which was acquired by Infratil and Commonwealth Superannuation Corporation in 2016.
Mr Koon Poh Low Non-Executive Director Jul 2020
Mr Low has 23 years of combined experience in accounting, auditing and consultancy, with experience in corporate finance, auditing, and accounting in various industries such as construction, plantation, hotels, property, manufacturing and marketing. Mr Low has served as the director of the Advanced Human Imaging since July 2020. Mr Low started his accounting services practice KL Management Services, based in Petaling Jaya, in 2006. Mr Low has also served the President of IPO Partners Limited, a corporate advisory firm since April 2015, and a director of Round Table Partners Berhad since 2019. Since June 2019, Mr Low has served the Executive Chairman and Chief Executive Officer of Medi Lifestyle Limited, a Healthcare and Wellness company listed in the Singapore Exchange. Prior to his position at KL Management Service, Mr Low worked as an auditor for an international audit firm, an accountant for a Japanese MNC, plus a couple of years as Financial Controller for two public listed companies in Malaysia. Mr Low is currently a director of Singaporean listed company, Medi Lifestyle Limited (appointed 1 June 2019).
Mr Edward F Greissing Jr Non-Executive Director Nov 2021
Mr Greissing Jr is a Senior Fellow with the Milken Institute, and the CEO of Greissing Strategic Advisors. Previously he was the Executive Director for the Centre of Public Health at the Milken Institute. Before his time with the Milken Institute, he served as a member of the Executive Committee, Global Leadership Team, and Senior Vice President of Corporate Affairs at Sanofi. During his nearly four decades in the biopharmaceutical industry, he led a range of Public Affairs and Global Corporate Affairs teams, first at the Upjohn Company and Pharmacia and later with Sanofi. His strategic approach to stakeholder management included new product launches and a freshness program for life cycle management. Previously he served as President and Chief Executive Officer of Red Line Associates, a consulting firm with clients from the biopharmaceutical, device, food service, and financial industries. Before entering the industry in 1978, he was on the U.S. Senate Intelligence Committee staff, served in the United States Army, and was a military policeman assigned to the Honor Detail at Fort Myer at Arlington Cemetery. He also chairs Corporate Governance Committee and is a member of Risk Management Committee as well as Compensation Committee.
Ms Luisa Ingargiola Non-Executive Director Feb 2021
Ms Ingargiola has almost 20 years of experience in public company finance, compliance, capital markets oversight and mergers and acquisitions. She currently serves as Chief Financial Officer of a NASDAQ biotech firm and Audit Chair of several Public companies including AgEagle (NYSE: UAVS), Vision Marine (NASDAQ:VMAR) and Progress Acquisition Corporation (NASDAQ:PGRWU), a new SPAC that recently completed their IPO. She has served multiple public companies in various Officer and Director roles. Ms Ingargiola has helped guide the uplist or IPO of several companies to NASDAQ or the NYSE.
Mr Simon Francis Durack Chief Financial OfficerCompany Secretary Mar 2022
Simon Francis Durack Chief Financial OfficerCompany Secretary

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Mad Scientist Pty Ltd 16,900,000 12.34%
The Rain Maker Mgmt Sdn Bhd 8,309,840 6.07%
Pheakes Pty Ltd <Senate A/C> 7,001,177 5.11%
Mr Nicholas John Blair Prosser 6,265,036 4.58%
Citicorp Nominees Pty Limited 5,512,816 4.03%
<The Vb Account> 5,391,864 3.94%
Dr. Amar El-Sallam 5,350,000 3.91%
Bnp Paribas Noms Pty Ltd <Drp> 3,753,355 2.74%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,654,442 2.67%
Terence Stupple 3,500,000 2.56%
Fitlab Fund Management Llc 3,000,000 2.19%
J15I Pte Ltd (W E F 16/06/2017) 2,466,375 1.80%
HSBC Custody Nominees (Australia) Limited 2,205,224 1.61%
Ifm Pty Limited 2,014,959 1.47%
Mr David Andrew Tabb 1,750,771 1.28%
Dennis And Janine Banks 1,662,898 1.21%
Mr John Zaccaria <The Zaccaria Share A/C> 1,300,000 0.95%
Mr Willy Chan Foo Weng 1,103,380 0.81%
Bnp Paribas Noms Pty Ltd <Uob Kay Hian Priv Ltd Drp> 1,076,263 0.79%
Netwealth Investments Limited <Wrap Services A/C> 965,596 0.71%